Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic screening in elderly starters on nortriptyline or venlafaxine
NL-OMON40010Active, not recruiting
- Sponsor
- University of Groningen
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nortriptyline and venlafaxine in major depressive disorder (MDD) (2 arms), sponsored by University of Groningen. Primary endpoint: Time to reach adequate serum drug levels. Started Feb 2013; status: active, not recruiting.
02
Drugs
nortriptylinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON40010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40010.